This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Ainnocence Technologies LLC. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Yutong Jin: Innovator in PROTAC Technology
Introduction
Yutong Jin is a prominent inventor based in Zhengzhou, China. He has made significant contributions to the field of drug development through his innovative approaches and methodologies. With a total of 4 patents, Jin is recognized for his advancements in PROTAC technology and ligand screening models.
Latest Patents
Yutong Jin's latest patents include a PROTAC target molecule generation method, a computer system, and a storage medium. The PROTAC target molecule generation method involves obtaining parameters and extracting target protein ligand structures from a database to form subsets. This method permutes and combines fragment structures to generate PROTAC target molecules, enhancing the accuracy of molecular design and accelerating drug research and development processes. Additionally, his ligand screening model construction method utilizes deep learning techniques to create a drug ligand screening model, which improves the efficiency of drug screening.
Career Highlights
Jin is currently associated with Ainnocence Technologies LLC, where he applies his expertise in molecular design and drug development. His work focuses on leveraging big data and computational processing to innovate in the pharmaceutical industry.
Collaborations
Yutong Jin collaborates with notable colleagues, including Lurong Pan and Junfeng Wu, to further enhance the research and development efforts in their field.
Conclusion
Yutong Jin's contributions to PROTAC technology and drug screening methodologies position him as a key figure in the innovation landscape. His work continues to influence advancements in drug research and development, showcasing the importance of collaboration and innovation in the scientific community.